Cystic Fibrosis Clinical Trial
Official title:
A Case Series Examining the Impact of a Positive Parenting Program (Self Directed Teen Triple P) on Treatment Adherence in Families With an Adolescent With Cystic Fibrosis
Cystic fibrosis (CF) is an illness that makes the lungs clog up with sticky mucus. There is no cure and so treatments are used to help make the illness easier to live with. The treatment can take lots of time and can feel not very nice sometimes. When children with CF become teenagers they need to learn to take charge of their treatment. This can be difficult. Teenagers with CF want to fit in with friends and can become more upset about their illness. Their parents have to learn to let their child take charge of their illness which can be hard for parents. These issues can put strain on parent-child relationships and this can make it harder for teenagers to stick to their treatment plans. A parenting program (called Teen Triple P) has been shown to help teenagers with other illnesses (such as diabetes) to be able to stick to their treatment plans. Parents are given a booklet to work through at home which helps them to build on the skills they already have. It aims to help families to support positive parent-child relationships, to manage difficult teenage behaviours, and to teach new skills and behaviours. So far no one has done any research to see if this program helps families of teenagers with CF. This research would like to see if the Triple P program can help teenagers with CF stick to their treatment plan. Helping teenagers stick to their treatment plan will help them to live happier and healthier lives.
The aim of this case series is to begin to explore whether the Teen Triple P program may
improve treatment adherence, parent-child relationships, parenting experiences and parent
and adolescent wellbeing in families with an adolescent with CF. Research commonly reports
that adherence rates to treatment are consistently lower in this age group, with variables
such as parent-child conflict, parent stress and the child's increasing independence all
being influential factors. Previous research has suggested that family based interventions
may facilitate with treatment adherence in this population, but little research has
investigated the effectiveness of specific parenting and family based interventions. Triple
P is an internationally recognized and extensively researched parenting intervention that
has been found to support families from an array of clinical and non-clinical samples, and
has been shown to reduce family conflict in other chronic health conditions. No research to
date has examined the use Triple P interventions in cystic fibrosis and so hence the current
research.
A within subjects clinical case series using an A-B multiple baseline design will be used.
This type of design exposes participating parents to a multiple baseline period (phase A)
followed by an intervention phase (phase B). This controls for potential confounds, which
increases confidence that change is attributable to the use of the parenting intervention.
The baseline phase will vary in length from 2 to 6 weeks. During this phase, parents will
complete the treatment adherence questionnaire and parenting scale (outlined in the outcome
measures section) at weekly intervals which will take 10 minutes each week (the first and
last baseline session will involve completing all questionnaires stated in the primary and
secondary outcome measures section). The baseline phase will be followed by the 10 week
intervention phase. Here parents will commence the self-directed Teen Triple P programme.
Parents will be posted a copy of the Teen Triple P workbook. They will complete a 1 hour
module of Triple P each week and will also continue to complete the treatment adherence
questionnaire and parenting scale each week. At week 5 and 10 of the intervention, the full
set of outcome questionnaires will be administered, as well as a satisfaction survey to
determine how parents are finding the Triple P intervention. Once the 10 week Triple P
intervention has been completed a period of 4 weeks will elapse before the researcher will
contact the parents again in order for them to complete a set of 1 month follow up
questionnaires, as well as answering some questions about their experiences of taking part
in the Triple P intervention.
Children themselves will not be required to participate in any study related activity as
this is primarily a parenting intervention.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |